Fill out this short form to see if you're eligible for treatment
The idea that a peptide from lizard venom could become a chronic therapy for a metabolic disease affecting millions seemed, on its face, preposterous
Kim HW, Jung YA, Yun JM, et al
Rated 5 out of 5 Ann-marie (verified owner) Verified review - view original Rated 5 out of 5 Joseph L
A second study using TriNetX, presented at the same ACR meeting session by Anna-Kay Palmer, MD, a 3rd-year internal medicine resident at Jefferson Einstein Hospital, Philadelphia, showed that GLP-1 RAs reduced the risk of progression to ESKD in patients with lupus nephritis, possibly due to reductions in pro-inflammatory mediators